These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 2417235

  • 1. Association of I-J determinants with lipomodulin/macrocortin.
    Jardieu P, Akasaki M, Ishizaka K.
    Proc Natl Acad Sci U S A; 1986 Jan; 83(1):160-4. PubMed ID: 2417235
    [Abstract] [Full Text] [Related]

  • 2. A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks.
    Steele JK, Kuchroo VK, Kawasaki H, Jayaraman S, Iwata M, Ishizaka K, Dorf ME.
    J Immunol; 1989 Apr 01; 142(7):2213-20. PubMed ID: 2466892
    [Abstract] [Full Text] [Related]

  • 3. Role of lipomodulin, a phospholipase inhibitory protein, in immunoregulation by thymocytes.
    Hirata F, Iwata M.
    J Immunol; 1983 Apr 01; 130(4):1930-6. PubMed ID: 6220071
    [Abstract] [Full Text] [Related]

  • 4. Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors.
    Iwata M, Huff TF, Ishizaka K.
    J Immunol; 1984 Mar 01; 132(3):1286-93. PubMed ID: 6363537
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response.
    Akasaki M, Jardieu P, Ishizaka K.
    J Immunol; 1986 May 01; 136(9):3172-9. PubMed ID: 2937840
    [Abstract] [Full Text] [Related]

  • 6. Modulation of the biologic activities of IgE-binding factors. VII. Biochemical mechanisms by which glycosylation-enhancing factor activates phospholipase in lymphocytes.
    Akasaki M, Iwata M, Ishizaka K.
    J Immunol; 1985 Jun 01; 134(6):4069-77. PubMed ID: 3872909
    [Abstract] [Full Text] [Related]

  • 7. Modulation of the biologic activities of IgE binding factor. VI. The activation of phospholipase by glycosylation enhancing factor.
    Iwata M, Akasaki M, Ishizaka K.
    J Immunol; 1984 Sep 01; 133(3):1505-12. PubMed ID: 6431000
    [Abstract] [Full Text] [Related]

  • 8. IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor.
    Jardieu P, Uede T, Ishizaka K.
    J Immunol; 1984 Dec 01; 133(6):3266-73. PubMed ID: 6208275
    [Abstract] [Full Text] [Related]

  • 9. Effect of phospholipase A2 inhibitors on mouse T lymphocytes. II. Phospholipase A2 inhibitors induce T cell hybridomas and a T cell clone for the formation of glycosylation-inhibiting factor.
    Ohno H, Iwata M, Katamura K, Ishizaka K.
    Int Immunol; 1990 Dec 01; 2(3):257-66. PubMed ID: 2128469
    [Abstract] [Full Text] [Related]

  • 10. Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation.
    Iwata M, Ishizaka K.
    J Immunol; 1988 Nov 15; 141(10):3270-7. PubMed ID: 2460527
    [Abstract] [Full Text] [Related]

  • 11. Biochemical characterization of murine glycosylation-inhibiting factor.
    Tagaya Y, Mori A, Ishizaka K.
    Proc Natl Acad Sci U S A; 1991 Oct 15; 88(20):9117-21. PubMed ID: 1924374
    [Abstract] [Full Text] [Related]

  • 12. Modulation of the biologic activities of IgE-binding factors. I. Identification of glycosylation-inhibiting factor as a fragment of lipomodulin.
    Uede T, Hirata F, Hirashima M, Ishizaka K.
    J Immunol; 1983 Feb 15; 130(2):878-84. PubMed ID: 6600257
    [Abstract] [Full Text] [Related]

  • 13. Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors.
    Jardieu P, Akasaki M, Ishizaka K.
    J Immunol; 1987 Mar 01; 138(5):1494-501. PubMed ID: 3492554
    [Abstract] [Full Text] [Related]

  • 14. Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin.
    Hirata F, Notsu Y, Iwata M, Parente L, DiRosa M, Flower RJ.
    Biochem Biophys Res Commun; 1982 Nov 16; 109(1):223-30. PubMed ID: 7159423
    [No Abstract] [Full Text] [Related]

  • 15. Further characterization of the glucocorticoid-induced antiphospholipase protein "renocortin".
    Rothhut B, Russo-Marie F, Wood J, DiRosa M, Flower RJ.
    Biochem Biophys Res Commun; 1983 Dec 28; 117(3):878-84. PubMed ID: 6667275
    [Abstract] [Full Text] [Related]

  • 16. Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases.
    Hirata F, del Carmine R, Nelson CA, Axelrod J, Schiffmann E, Warabi A, De Blas AL, Nirenberg M, Manganiello V, Vaughan M, Kumagai S, Green I, Decker JL, Steinberg AD.
    Proc Natl Acad Sci U S A; 1981 May 28; 78(5):3190-4. PubMed ID: 6114491
    [Abstract] [Full Text] [Related]

  • 17. In vitro modulation of antigen-primed T cells by a glycosylation-inhibiting factor that regulates the formation of antigen-specific suppressive factors.
    Iwata M, Ishizaka K.
    Proc Natl Acad Sci U S A; 1987 Apr 28; 84(8):2444-8. PubMed ID: 2951740
    [Abstract] [Full Text] [Related]

  • 18. Effect of phospholipase A2 inhibitors on mouse T lymphocytes. I. Phospholipase A2 inhibitors exert similar immunological activities as glycosylation inhibiting factor.
    Ohno H, Iwata M, Nakamura T, Ishizaka K.
    Int Immunol; 1989 Apr 28; 1(4):425-33. PubMed ID: 2535136
    [Abstract] [Full Text] [Related]

  • 19. Anti-I-J alloantisera elicited by immunization of B10.A(3R) (I-Jb) mice with bone marrow-derived macrophages from B10.A(5R) (I-Jk) mice.
    Bradley LM, Shiigi SM, Malley A.
    Immunology; 1986 Mar 28; 57(3):443-9. PubMed ID: 3957408
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulin, a phospholipase inhibitory protein.
    Hattori T, Hirata F, Hoffman T, Hizuta A, Herberman RB.
    J Immunol; 1983 Aug 28; 131(2):662-5. PubMed ID: 6223089
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.